628 antibodies registered
Antibody ID ∧ ∨ | Antibody name ∧ ∨ | Epitope ID ∧ ∨ | Epitope name ∧ ∨ | Recognition region ∧ ∨ |
---|---|---|---|---|
AN0212 | 38.13 | EP0071 | Gb3 | Gal(a1-4)Gal(b1-4)Glc-R |
AN0534 | 3A5 | EP0252 | Blood Group H Type 2 | Fuc(a1-2)Gal(b1-4)GlcNAc(b1-)-R |
AN0057 | 3A7 | EP0257 | Blood Group A Type 2 | GalNAc(a1-3)[Fuc(a1-2)]Gal(b1-4)GlcNAc-R Gal(a1-3)[Fuc(a1-2)]Gal(b1-4)GlcNAc-R |
AN0057 | 3A7 | EP0262 | Blood Group B Type 2 | GalNAc(a1-3)[Fuc(a1-2)]Gal(b1-4)GlcNAc-R Gal(a1-3)[Fuc(a1-2)]Gal(b1-4)GlcNAc-R |
AN0777 | 3C9 | EP0020 | T Antigen | Gal(b1-3)GalNAc(a1-)Ser/Thr |
AN0609 | 3E8 | EP0007 | Lewis a | Gal(b1-3)[Fuc(a1-4)]GlcNAc(b1-)-R Neu5Ac(a2-3)Gal(b1-3)[Fuc(a1-4)]GlcNAc(b1-)-R |
AN0609 | 3E8 | EP0008 | Sialyl Lewis a | Gal(b1-3)[Fuc(a1-4)]GlcNAc(b1-)-R Neu5Ac(a2-3)Gal(b1-3)[Fuc(a1-4)]GlcNAc(b1-)-R |
AN0782 | 3F1 | EP0022 | Sialyl Tn Antigen | Neu5Ac(a2-6)GalNAc(a1-)Ser |
AN0823 | 3F11 | EP0400 | N-Acetyllactosamine | Gal(b1-4)GlcNAc-R |
AN0747 | 3F74 | EP0011 | Lewis x | Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-)-R |
AN0409 | 3F8 | EP0061 | GD2 | GalNAc(b1-4)[Neu5Ac(a2-8)Neu5Ac(a2-3)]Gal(b1-4)Glc(b1-1)Cer |
AN0451 | 3G10 | EP0087 | Delta-Heparan Sulfate | Heparan sulfate neo-epitope generated by digesting heparan sulfate with heparitinase from Flovobacterium heparinum |
AN0410 | 3G6 | EP0061 | GD2 | GalNAc(b1-4)[Neu5Ac(a2-8)Neu5Ac(a2-3)]Gal(b1-4)Glc(b1-1)Cer |
AN0745 | 3G75 | EP0011 | Lewis x | Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-)-R |
AN0222 | 3H1 | EP0250 | Blood Group H Disaccharide | Fuc(a1-2)Gal(b1-)-R Fuc(a1-2)Gal(b1-3)GlcNAc(b1-)-R Fuc(a1-2)Gal(b1-4)GlcNAc(b1-)-R Fuc(a1-2)Gal(b1-3)GalNAc(a1-)-R Fuc(a1-2)Gal(b1-3)GalNAc(b1-)-R |
AN0222 | 3H1 | EP0251 | Blood Group H Type 1 | Fuc(a1-2)Gal(b1-)-R Fuc(a1-2)Gal(b1-3)GlcNAc(b1-)-R Fuc(a1-2)Gal(b1-4)GlcNAc(b1-)-R Fuc(a1-2)Gal(b1-3)GalNAc(a1-)-R Fuc(a1-2)Gal(b1-3)GalNAc(b1-)-R |
AN0222 | 3H1 | EP0252 | Blood Group H Type 2 | Fuc(a1-2)Gal(b1-)-R Fuc(a1-2)Gal(b1-3)GlcNAc(b1-)-R Fuc(a1-2)Gal(b1-4)GlcNAc(b1-)-R Fuc(a1-2)Gal(b1-3)GalNAc(a1-)-R Fuc(a1-2)Gal(b1-3)GalNAc(b1-)-R |
AN0222 | 3H1 | EP0253 | Blood Group H Type 3 | Fuc(a1-2)Gal(b1-)-R Fuc(a1-2)Gal(b1-3)GlcNAc(b1-)-R Fuc(a1-2)Gal(b1-4)GlcNAc(b1-)-R Fuc(a1-2)Gal(b1-3)GalNAc(a1-)-R Fuc(a1-2)Gal(b1-3)GalNAc(b1-)-R |
AN0222 | 3H1 | EP0254 | Blood Group H Type 4 | Fuc(a1-2)Gal(b1-)-R Fuc(a1-2)Gal(b1-3)GlcNAc(b1-)-R Fuc(a1-2)Gal(b1-4)GlcNAc(b1-)-R Fuc(a1-2)Gal(b1-3)GalNAc(a1-)-R Fuc(a1-2)Gal(b1-3)GalNAc(b1-)-R |
AN0729 | 3H1 (Keratan Sulfate) | EP0085 | Keratan Sulfate | Keratan sulfate |
AN0066 | 3S193 | EP0018 | Lewis y | Fuc(a1-2)Gal(b1-4)[Fuc(a1-3)]GlcNAc-R |
AN0415 | 4.2 | EP0062 | N-Acetyl GD3 | Neu5Ac(a2-8)Neu5Ac(a2-3)Gal(b1-4)Glc(b1-1)Cer |
AN0229 | 43-9F | EP0091 | Lewis a- Lewis x Hybrid Antigen | Gal(b1-3)[Fuc(a1-4)]GlcNAc(b1-3)Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-)-R |
AN0144 | 473A12 | EP0081 | Chondroitin | -[GlcA(b1-3)GalNAc(b1-4)]n- |
AN0135 | 49-D6 | EP0079 | SM3 | HSO3(-3)Gal(b1-4)Glc(b1-1)Cer HSO3(-3)Gal(b1-3)GalNAc(b1-4)[HSO3(-3)]Gal(b1-4)Glc(b1-1)Cer |